SCHEMBL6785803

SCHEMBL6785803

C=CCc1c(C(O)(C=C)CC)ccnc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6793809 0.89 CCNB2 (0.33)
SCHEMBL6786549 0.70 CCNB2 (0.31)
SCHEMBL6786551 0.70 CCNB2 (0.31)
SCHEMBL6788615 0.69 RXRA (0.33)
SCHEMBL6788259 0.69 PDE2A (0.34)
SCHEMBL6789137 0.67 CCNB2 (0.35)
SCHEMBL7454862 0.63 SLC13A5 (0.30)
SCHEMBL21742136 0.62 SMN1; SMN2 (0.55)
SCHEMBL6787926 0.61 KDM4E (0.32)
SCHEMBL24140202 0.59 MEN1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699876-B2 FOR CANCER THERAPY LES LABORATOIRES SERVIER (FR) 2004-03-02 US disclosed
US-20030105109-A1 For cancer therapy LES LABORATOIRES SERVIER (FR) 2003-06-05 US disclosed
US-6509345-B2 For therapy of cancerous diseases LES LABORATOIRES SERVIER (FR) 2003-01-21 US disclosed
EP-1101765-B1 Camptothecin analogues, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2002-08-14 EP disclosed
US-20020077325-A1 New camptothecin analogue compounds LAVIELLE GILBERT (FR) 2002-06-20 US disclosed
EP-1101765-A2 Camptothecin analogues, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 2001-05-23 EP disclosed